Press release and another news release from the Binatyara Foundation, USA & the Binaytara Foundation Cancer Center, Janakpurdham, Nepal.
Presented by: Dr. Stephen S. Grubbs As we look at quality through value-based solutions, there are many perspectives to…
By: Dr. Anish ShahBronx-Lebanon Hospital; Bronx, NY On April 5, 2024, the Food and Drug Administration granted accelerated approval forfam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On March 1, 2024, the U.S. Food and Drug Administration approved amivantamab- vmjw (Rybrevant,…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY The FDA gave its approval for the use of osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP)…
By: Dr. Anish ShahBronx-Lebanon Hospital; Bronx, NY On February 16, 2024, the U.S. Food and Drug Administration granted accelerated approval to lifileucel (Amtagvi).…
By: Dr. Anish ShahBronx-Lebanon Hospital; Bronx, NY On February 15, 2024, the U.S. Food and Drug Administration granted regular approval to tepotinib (Tepmetko)…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On February 13, 2024, the U.S. Food and Drug Administration granted approval for the…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On December 13, 2023, the U.S. Food and Drug Administration granted approval to eflornithine…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY The U.S. Food and Drug Administration gave its approval for the use of enfortumab…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On December 14, 2023, the U.S. Food and Drug Administration granted approval to belzutifan…